Evidence map›Paper›PMID 32676028›Full record

ArticleFrontiers in pharmacology2020

Recombinant

Xinhua Lei, Chenyang Zhi, Wei Huang, Xilin Sun, Weiyang Gao, Xue Yin, Xin Zhang, Chongyang Liang, Haoran Zhang, Fei Sun

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Antioxidants (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xinhua LeiSchool of Pharmaceutical Sciences, Jilin University, Changchun, China.
Chenyang ZhiAnorectal, Changchun University of Traditional Chinese Medicine Affiliated Hospital, Changchun, China.
Wei HuangSchool of Pharmaceutical Sciences, Jilin University, Changchun, China.
Xilin SunSchool of Pharmaceutical Sciences, Jilin University, Changchun, China.
Weiyang GaoSchool of Pharmaceutical Sciences, Jilin University, Changchun, China.
Xue YinSchool of Pharmaceutical Sciences, Jilin University, Changchun, China.
Xin ZhangDepartment of New Drug Development, Changchun Intellicrown Pharmaceutical Co. LTD, Changchun, China.
Chongyang LiangSchool of Pharmaceutical Sciences, Jilin University, Changchun, China.
Haoran ZhangNeurosurgery, Gaoyou People's Hospital, Yangzhou, China.
Fei SunSchool of Pharmaceutical Sciences, Jilin University, Changchun, China.
Jilin University · CNChangchun University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

colony-stimulating factor 1 receptorgranulocyte-colony stimulating factorhematopoietic stem cellsneutropeniarLZ-8

Identifiers

PMID32676028
PMCPMC7333219
OpenAlexW3037442906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.